Will a urine drug panel with an amphetamine (AMP) cutoff of 1000 ng/mL detect ADHD medications such as Concerta (methylphenidate) or Vyvanse (lisdexamfetamine)?

Amphetamine Drug Panel Detection of ADHD Medications

An amphetamine (AMP) urine drug panel with a 1000 ng/mL cutoff will detect Vyvanse (lisdexamfetamine) but will NOT detect Concerta (methylphenidate).

Key Distinction: Two Different Drug Classes

Vyvanse (Lisdexamfetamine) - WILL BE DETECTED

Vyvanse is a prodrug that converts to dextroamphetamine in the bloodstream 1. After oral administration, lisdexamfetamine is rapidly hydrolyzed by red blood cells to produce dextroamphetamine and L-lysine 1. This means:

• Vyvanse will test positive on amphetamine panels because it metabolizes directly to amphetamine
• The detection window is approximately 67-77 hours (roughly 3 days) after a single therapeutic dose 2
• At the 1000 ng/mL cutoff, detection rates are high for at least 24 hours after intake 2

Concerta (Methylphenidate) - WILL NOT BE DETECTED

Concerta contains methylphenidate, which is a completely different chemical structure from amphetamines. Methylphenidate:

• Does NOT cross-react with amphetamine immunoassays 3
• Metabolizes to ritalinic acid, not amphetamine metabolites 2
• Requires a separate, specific test panel to detect
• Is chemically and metabolically distinct from the amphetamine class

Clinical Context from Guidelines

The AAP Pediatrics guidelines explicitly address this issue: "A patient taking amphetamine and dextroamphetamine for attention-deficit/hyperactivity disorder will have a positive test result for amphetamines" 3. However, the guidelines note that standard test panels often miss substances with variant metabolism 3, which is precisely why methylphenidate requires its own specific assay.

Important Caveats

For Vyvanse detection:

• The 1000 ng/mL cutoff may miss low doses or samples collected >3-5 days after last use 4, 5
• Urine pH significantly affects amphetamine excretion - alkaline urine reduces detection 4
• Individual variability in detection times is substantial 2

For accurate interpretation:

• Always obtain complete medication history before interpreting results 3
• Drug testing cannot distinguish between prescribed use and misuse 3
• Consider confirmatory testing (GC-MS) if results don't match clinical picture 3

Bottom Line Algorithm

1. If patient takes Vyvanse → Expect positive AMP screen (assuming compliance and recent use)
2. If patient takes Concerta → Expect negative AMP screen; requires separate methylphenidate test
3. If AMP screen is positive → Confirm with GC-MS to distinguish prescribed amphetamines from illicit use
4. If clinical suspicion doesn't match results → Contact the testing laboratory for guidance 3